DisclaimerThis section contains abbreviated prescribing information/full prescribing information/leaflet of prescription product portfolio of Sanofi India Ltd, Sanofi-Synthelabo (India) Ltd. and Sanofi Pasteur (India) Pvt. Ltd.
Scientific information is continually being updated; the abbreviated prescribing information is based on current knowledge and is subject to change. Should there be any specific concerns please write to: Sanofi India Limited/Sanofi-Synthelabo (India) Private Limited/Sanofi Pasteur (India) Private Limited, CTS No.117-B, L&T Business Park, Saki Vihar Road, Powai, Mumbai 400072.
Contact for medical information or pharmacovigilanceFor reporting adverse events: PV.firstname.lastname@example.org
For medical information (healthcare professionals only): email@example.com
All consumers or patients are advised to contact their doctor or healthcare professional for advice on medicines or any health matters/medical emergencies.
Pharmacovigilance remains a key activity in the assessment of the therapeutic value of products. Sanofi ensures continuous monitoring and management of the safety profile of all its products through its drug safety data collection worldwide. A key activity of Sanofi is to provide updated medical information in compliance with Indian regulations, on its products, to healthcare professionals.
You can email or call us between 9AM and 5PM on any working day (we are closed on Saturday, Sunday and public holidays). Please select IVRS option 1 for medical information and IVRS option 3 for reporting adverse events.